Irving Boime

This inventor holds 25 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in Glycoprotein Hormones. Top assignees: Washington University, Leland Stanford Junior University, University of California. Active years: 1993-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Irving Boime. Retrieved from https://idiyas.com/inventor/irving-boime

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 92.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 1.5

ph-index = 15

Forward Citations = 755(Granted Patents)

Company Filing History:

25 out of 1,379

Washington University

patents

1 out of 5,509

Leland Stanford Junior University

patents

1 out of 16,008

University of California

where one patent can have more than one assignee

Years Active: 1993-2014

Loading Chart...

Areas of Expertise:

Glycoprotein Hormones

Follicle Stimulating Hormone

Recombinant Production

Hormone Analogs

Single-Chain Hormones

CTP Extensions

Gonadotropins

Peptide Modifications

Assay Systems

Receptor Antagonists

Pharmaceutical Peptides

DNA Encoding

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8835386 - Activity of recombinant equine follicle stimulating hormone (2014-09-16),

2. 7442376 - Glycoprotein hormone compositions containing two β subunits (2008-10-28),

3. 6987172 - Multifunctional single chain glycoprotein hormones comprising three or more β subunits (2006-01-17),

4. 6737515 - Follicle stimulating hormone-glycosylation analogs (2004-05-18),

5. 6693074 - Cystine depleted glycoprotein hormones (2004-02-17),

6. 6689365 - Single-chain fertility hormones with fsh and LH activity (2004-02-10),

7. 6635256 - Glycoprotein hormone compositions comprising two &bgr; subunits and methods of use thereof (2003-10-21),

8. 6306654 - Follicle stimulating hormone-glycosylation analogs (2001-10-23),

9. 6242580 - Single-chain forms of the glycoprotein hormone quartet (2001-06-05),

10. 6238890 - Single chain forms of the glycoprotein hormone quartet (2001-05-29),

11. 6225449 - Hormone analogs with multiple CTP extensions (2001-05-01),

12. 6103501 - Single chain glycoprotein hormones comprising two .beta. and one .alpha. (2000-08-15),

13. 6028177 - Methods of detecting single-chain forms of the glycoprotein hormone (2000-02-22),

14. 5985611 - Recombinant production of gonadotropins in secretory cells (1999-11-16),

15. 5958737 - Single-chain .beta. subunit dimers of the glycoprotein hormones and (1999-09-28),

Title: **Irving Boime: Innovator in Equine Reproductive Technologies**

Introduction

Irving Boime, based in St. Louis, Missouri, is a prominent inventor with an impressive portfolio of 25 patents. His groundbreaking work primarily focuses on advancements in reproductive technologies, particularly for equine and other mammals.

Latest Patents

One of Boime's notable recent inventions is related to the "Activity of recombinant equine follicle stimulating hormone." This innovation presents methods for producing biologically active recombinant eFSH analogs, which significantly enhance reproduction in mammals, especially equine species. His inventions include methods that promote superovulation, follicular development, embryo development, and overall reproductive efficiency in horses, cattle, and other ungulates.

Additionally, he has developed glycoprotein hormone compositions that comprise differentially acting glycoprotein hormones. These compositions involve specific formulations that utilize various subunits and linkers to optimize their effectiveness in reproductive applications.

Career Highlights

Throughout his career, Irving Boime has been associated with prestigious institutions such as Washington University and Washington University in St. Louis. His contributions to the field of reproductive biology have established him as a leading figure in innovating methods that improve fertility and reproductive outcomes in mammals.

Collaborations

Throughout his research, Boime collaborated with notable scientists including Martin M Matzuk and David Ben-Menahem. These partnerships have allowed for a rich exchange of ideas and propelled the advancement of reproductive technologies through their combined expertise.

Conclusion

Irving Boime's innovations in the field of reproductive science are paving the way for new methods that enhance fertility in mammals. His dedication to developing recombinant technologies and glycoprotein hormone compositions stands as a testament to his impactful contributions to science and the welfare of animals. His ongoing work continues to inspire future advancements in reproductive health.

Profile summary based on public USPTO records.